Jury Orders Bayer, J&J to Pay $28 Million in Xarelto Lawsuit

Xarelto® is an oral anticoagulant intended to thin the blood and prevent clotting, especially after certain surgeries. The drug is manufactured by Bayer and marketed by Janssen Pharmaceuticals, an affiliate of Johnson & Johnson. Xarelto® has been linked to uncontrollable bleeding, a side effect that can quickly claim lives. Read more about the recent trial here.

Author: Audrey Snyder

Audrey Snyder is an attorney supporting the firm in the areas of injury claims, including defective products, occupational diseases, and workers’ compensation. She began working with Ward Black Law late in 2017 as a contract attorney and formally joined the team in the spring of 2018.  She engages her passion for helping the defenseless and has a desire to “stand up for the little guy.”